Issue 13, 2023

Copper iodide microhexagons: a potential therapeutic agent for surface microbial infection and melanoma

Abstract

Microbial infections are a constant threat to humans and responsible for increased death rate in most of the developing countries. Conventional use of chlorine- or alcohol-based disinfectants results in the development of drug-resistant microbial strains, which are limited in their response to most of the treatment strategies. In this perspective, several engineered materials have emerged as an affordable alternative to the existing treatment strategies. For the same, here we have synthesised CuI microparticles (CuI (WH) and CuI (H)) using chemical precipitation followed by a hydrothermal process. We further comparatively evaluated the antiproliferative activity of CuI (WH) and CuI (H) against microbial cultures (non-resistant and resistant), virus, and cancer cell lines. CuI (H) displayed better size, stability, and significantly higher inhibitory activity against microorganisms and cancer cell lines than CuI (WH). Upon preliminary evaluation, which confirmed that CuI (H) is more effective than CuI (WH), we evaluated its stability and surface sterilising property, and it was found that CuI (H) were stable for the recorded period of 30 days and displayed significant surface sterilising ability. The results suggest that CuI (H) is a potent antiproliferative material against microbial cultures, viral strains, and cancer cell lines while preserving its biocompatibility towards normal cell lines, representing a potential surface sterilising material in public places upon significant in vivo efficacy evaluation.

Graphical abstract: Copper iodide microhexagons: a potential therapeutic agent for surface microbial infection and melanoma

Supplementary files

Article information

Article type
Paper
Submitted
07 Mar 2023
Accepted
05 Jun 2023
First published
26 Jun 2023
This article is Open Access
Creative Commons BY-NC license

Mater. Adv., 2023,4, 2853-2867

Copper iodide microhexagons: a potential therapeutic agent for surface microbial infection and melanoma

S. V. Pogu, D. N. Yadav, S. A. Sankaranarayanan, R. Srivastava, S. Thatikonda and A. K. Rengan, Mater. Adv., 2023, 4, 2853 DOI: 10.1039/D3MA00110E

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements